In the quiet evolution of personal health technology, Samsung has extended the reach of its Galaxy Watch 3 and Active 2 into territory once reserved for clinical settings — offering wrist-based blood pressure monitoring to everyday users. The feature, arriving in late February 2021, relies on pulse wave analysis rather than direct pressure measurement, and asks users to anchor its accuracy with monthly calibrations using a traditional arm cuff. It is a meaningful step in the long-running pursuit between Samsung and Apple to define what a smartwatch can mean for human wellbeing.
Screen Rant
· Feb 23, 2021
· technology
· 3 min de lectura
High
Verificación: Verificado
Samsung Galaxy Watch 3 & Active 2 Now Offer Blood Pressure Monitoring
◉
Technology
7880 artículos relacionados
Samsung Galaxy S26 Plus vs iPhone 17 Pro Max: Which 2026 Flagship Wins…
International Business Times · 100% coincidencia
Samsung Galaxy S26 series launches today with AI-powered features and …
Zee News · 99% coincidencia
AI Giants Boost H-1B Filings While Tech Peers Pull Back on Visa Recrui…
The Economic Times · 99% coincidencia
Tech Leaders Promise AI Will Cut Work Hours—Their Staff Work 90-Hour W…
BBC News · 99% coincidencia
AI models breach sandbox limits in wave of security incidents
BBC News · 99% coincidencia
Cobertura Relacionada
Boss Hunting · Aug 11
Tech gifts for dad: 20 gadgets from fitness wearables to smart home upgrades
A curated gift guide featuring premium tech products across audio, fitness, home automation and travel categories for te…
Brisbane Times · Aug 11 Brisbane pools to trial AI cameras for drowning detectionBrisbane City Council will trial AI-powered drowning detection cameras at two public pools to alert lifeguards of swimme…
Nature · Aug 11 AI model identifies lead contamination risk across cities with limited dataResearchers developed a self-supervised graph neural network that accurately identifies lead contamination risk in resid…
Huawei Central · Aug 11 Huawei Mate XT 2 could be 30% flatter with U-shaped designHuawei's upcoming Mate XT 2 tri-foldable smartphone, launching September 2026, will be 30% flatter and lighter than its …
Sesgo y Encuadre
⚖
Article presents Samsung's blood pressure feature as a competitive achievement with neutral product coverage, though framing emphasizes Samsung's catch-up narrative to Apple.
Bias Direction
center
Confidence
MED
Competitive narrative framing that positions Samsung's feature launch within a historical Apple-Samsung rivalry context, emphasizing Samsung's delayed response to Apple's ECG capability as a 'big win' and 'catch-up' moment.
big win for Samsung
quickly overtook the market
distanced itself even further
looking to move beyond
User experience or reliability comparisons with Apple Watch blood pressure monitoring
Medical professionals' assessment of the pulse wave analysis method vs. traditional cuff measurement
Competitor perspectives (Fitbit, Garmin, etc.) on their blood pressure monitoring capabilities
Privacy/data security considerations for health monitoring features
Cost comparison with competing smartwatches offering similar features
Impacto Geopolítico
🌎
This article discusses Samsung's consumer smartwatch health feature and has no geopolitical implications.
Escalation Risk
low
Confidence
HIGH
Lente Económico
📈
Samsung's blood pressure monitoring feature on Galaxy Watch 3/Active 2 strengthens its wearables market position against Apple, potentially driving device sales and expanding health-tech ecosystem adoption.
Market Signal
bullish
Confidence
HIGH
Consumer Electronics & Wearables
Healthcare Technology
Digital Health Services
Smartphone Manufacturing
Consumers gain affordable continuous health monitoring without additional devices, reducing healthcare friction and encouraging wearable adoption. However, monthly calibration requirement creates ongoing engagement but may frustrate users seeking full autonomy.
Regulatory scrutiny likely regarding medical device classification, data privacy for health information, and accuracy standards. FDA clearance precedent suggests Samsung will pursue formal medical device validation, potentially enabling insurance reimbursement and clinical adoption.